Pharmaceutical crystallization and formulation
Ideas about drug substances and drug products, from crystallizing active ingredients to formulation, solid dosage forms and biopharmaceutical manufacturing.
Who funds this idea
26 calls from 14 funders currently fund work on this idea. Most calls: NIH (9), European Commission (Horizon Europe) (3), Innovate UK (2), Rinn Pharma & Biopharma / SSPC (2), FFG – Austrian Research Promotion Agency (1), NIIMBL (National Institute for Innovation in Manufacturing Biopharmaceuticals) (1), and 8 other funders.8 calls for this idea welcome industry or international partners
Open now (20)
CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)
Deadline: 05 Nov 2026 (14 days)
chemistrypharma processestablished / PI
MDI Programme Innovation and Scale-up Hub
Deadline: 18 Nov 2026 (27 days)
pharma processestablished / PI
Sustainable Medicines Manufacturing Innovation: CR&D round 2
Deadline: 02 Dec 2026 (41 days)
pharma processcrystallizationchemistryestablished / PI
FFG Basisprogramm 2026 (company R&D projects, any topic)
Deadline: 31 Dec 2026 (70 days)
crystallizationpharma processchemistryestablished / PI
NIIMBL Project Call 10.1 (biopharmaceutical manufacturing technology & workforce)
Deadline: 07 Jan 2027 (77 days)
crystallizationpharma processestablished / PIindustry / SME
Limited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 Clinical Trial Not Allowed, PAR-27-067)
Deadline: 26 Jan 2027 (96 days)
chemistrymaterialspharma processestablished / PIearly-careerinstrument / beamtime
Small molecule high throughput screen using AstraZeneca facilities
Deadline: 28 Jan 2027 (98 days)
chemistrypharma processestablished / PI
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)
Deadline: 05 Mar 2027 (134 days)
chemistrypharma processestablished / PI
Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed, PAR-27-021)
Deadline: 01 Jul 2027 (252 days)
chemistrymaterialspharma processestablished / PIearly-careerinstrument / beamtime
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
Deadline: 25 Oct 2027 (368 days)
pharma processestablished / PI
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
Deadline: 25 Oct 2027 (368 days)
pharma processestablished / PI
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Deadline: 05 Nov 2027 (379 days)
chemistrypharma processestablished / PI
Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
Deadline: 07 Jan 2028 (442 days)
chemistrypharma processestablished / PI
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Deadline: 20 Feb 2029 (852 days)
chemistrypharma processestablished / PI
BARDA Broad Agency Announcement (medical countermeasures, incl. manufacturing platforms)
Deadline: Areas of interest listed; no closing date on the page – check the funder page
pharma processindustry / SME
C-SOPS industry membership / sponsored projects
Deadline: Rolling / no fixed deadline
pharma processestablished / PI
CMAC CEDAR EPSRC CDT PhD studentships (medicines manufacturing)
Deadline: Rolling / no fixed deadline
pharma processcrystallizationstudent
Enabling Technologies Consortium (ETC) RFI/RFPs and third-party project proposals
Deadline: Rolling / no fixed deadline
pharma processcrystallizationestablished / PI
Rinn Pharma & Biopharma (ex-SSPC) PhD positions
Deadline: Rolling / no fixed deadline
pharma processcrystallizationstudent
SSPC/Rinn industry-led research projects (fully funded or up to 50% co-funding)
Deadline: Rolling / no fixed deadline
pharma processcrystallizationestablished / PI
Opening soon (3)
Development of cell-free protein synthesis platforms for discovery and/or production of biologicals
Opening soon: not yet open
Deadline: 17 Feb 2027 (118 days)
chemistrypharma processestablished / PI
Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Opening soon: not yet open
Deadline: 17 Feb 2027 (118 days)
chemistrypharma processestablished / PI
Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Opening soon: not yet open
Deadline: 17 Feb 2027 (118 days)
pharma processestablished / PI
Recurring calls (3)
AIChE PD2M Forum Awards (Technical Innovation, Process Development, Manufacturing, Early Career Impact, Student)
Deadline: Recurring call (recurring (annual)): check the funder page for the next date.
pharma processcrystallizationstudentearly-careerestablished / PIearly-career / new PIprize / nomination
EFCE Excellence Award in Crystallization
Deadline: Recurring call (closed – next call 2028): check the funder page for the next date.
crystallizationpharma processstudentearly-careerprize / nomination
FDA Broad Agency Announcement for Advanced Research and Development of Regulatory Science (FY26: FDABAA-26-00123)
Deadline: Recurring call (closed for FY26 (response date 24 Feb 2026; notice inactive 30 Sep 2026); recurring annually): check the funder page for the next date.
crystallizationpharma processchemistryestablished / PI
Recently funded work on this idea
10 awards from NSF and NIH in our sample of the last 24 months match this idea. Latest examples:
| Award (official page) | Institution | Amount | Start date |
|---|---|---|---|
| Collaborative Research: Investigating the Molten Salt Synthesis of Metal Oxide Nanoparticles via in situ X-ray Scattering/Spectroscopy Techniques | Virginia Polytechnic Institute and State University | $270,000 | 01 Mar 2026 |
| Ion Hydration and Nanodrops in Mass Spectrometry | University of California-Berkeley | $600,000 | 01 Feb 2026 |
| Integrating Machine Learning and Atomistic Simulations for Accurate Prediction of Drug Molecular Crystal Solubility | University Of California Berkeley | $401,250 | 15 Sep 2025 |
| NMR strategies to probe allosteric effects of inhibitor binding on AML-associated Src-family kinases | University Of Pittsburgh At Pittsburgh | $151,920 | 01 Sep 2025 |